• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Arbutus Biopharma Corporation (ABUS)

    -NasdaqCM
    7.36 Up 0.09(1.24%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.27
    Open:7.15
    Bid:6.90 x 10000
    Ask:8.00 x 100
    1y Target Est:23.79
    Beta:-1.19333
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:7.15 - 7.48
    52wk Range:6.23 - 29.93
    Volume:514,852
    Avg Vol (3m):612,163
    Market Cap:399.86M
    P/E (ttm):N/A
    EPS (ttm):-1.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.38
    Quarterly EPS Est (Sep-15) :-0.31
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arbutus Biopharma Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics, and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback